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To determine the cause of acute febrile illnesses other 
than malaria in the North Eastern Province, Kenya, we in-
vestigated rickettsial infection among patients from Garissa 
Provincial Hospital for 23 months during 2006–2008. Nucle-
ic acid preparations of serum from 6 (3.7%) of 163 patients 
were positive for rickettsial DNA as determined by a genus-
speciﬁ  c quantitative real-time PCR and were subsequently 
conﬁ  rmed by molecular sequencing to be positive for Rick-
ettsia felis. The 6 febrile patients’ symptoms included head-
ache; nausea; and muscle, back, and joint pain. None of the 
patients had a skin rash.
R
ickettsial diseases are found worldwide and are caused 
by infection with obligate intracellular rickettsiae, 
which are transmitted to humans by arthropod vectors (e.g., 
lice, ﬂ  eas, ticks, and mites). Rickettsiae are associated with 
arthropods for a least a part of their life cycle and are passed 
to other arthropods by transovarial transmission or horizon-
tal transmission involving vertebrate hosts (1). Rickettsiae 
are small, gram-negative, fastidious bacteria of the α sub-
division of Proteobacteria, which are frequently divided 
into 2 groups based on antigenicity, G+C content, culture 
conditions, and actin polymerization: 1) the typhus group 
including Rickettsia prowazekii and R. typhi, the causative 
agents of louse-borne epidemic and ﬂ  ea-borne murine ty-
phus, and 2) the spotted fever group including >20 species 
that may cause tick-, ﬂ  ea-, and mite-borne rickettsioses (2). 
Infection of humans by rickettsiae often begins at the site 
of the bite of the arthropod vector and subsequently spreads 
through the draining lymph nodes throughout the body, re-
sulting in infection of endothelial cells, which can lead to 
multiorgan pathologic changes associated with potentially 
life-threatening diseases (1).
Little is known about the full spectrum of rickettsial 
diseases that occur in Kenya. One frequently reported rick-
ettsial disease has been described in many parts of Kenya 
as Kenya fever, Kenya typhus, Kenya tick fever, or Kenyan 
tick typhus (3,4). This disease was initially thought to be 
caused by a single pathogen, R. conorii, the causative agent 
of Mediterranean spotted fever (5). However, recently, a sec-
ond agent has been suggested as a cause of at least a portion 
of these rickettsioses (6,7), R. africae, the causative agent of 
African tick-bite fever. In addition to the tick-borne spotted 
fever disease, ﬂ  ea-borne murine typhus is known to occur in 
Kenya, especially in urban areas where the house rat (Rattus 
rattus) is prevalent (4,8). However, louse-borne epidemic ty-
phus does not appear to be endemic to Kenya (4).
The objective of the hospital-based surveillance we 
report here was to determine the etiologic agents of non-
malaria acute febrile illnesses in the North Eastern Prov-
ince, Kenya, during a period when there is no Rift Valley 
fever (RVF) epidemic in the country. The North Eastern 
Province was severely affected by the 2 most recent RVF 
epidemics in the Eastern Africa region; >89,000 human 
RVF infections occurred during the 1997–98 epidemic 
and >300 acute cases occurred during the 2006–2007 epi-
demic (9,10). Therefore, the surveillance was established 
to investigate whether acute RVF cases occurred during in-
terepidemic periods. As part of this investigation, we also 
investigated the occurrence of other causes of fever that 
are not routinely tested for at the local hospitals, including 
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rickettsiosis, brucellosis, leptospirosis, and other viral in-
fections. The study protocol was approved by the institu-
tional review boards of the US Centers for Disease Control 
and Prevention, US Naval Medical Research Center, and 
Kenya Medical Research Institute in compliance with all 
applicable regulations governing the protection of human 
subjects.
Materials and Methods
Study Site
This hospital-based study was conducted at the Ga-
rissa Provincial Hospital in Garissa town, located in North 
Eastern Province, Kenya (Figure). The semiarid province 
has an average annual rainfall <40 mm; is inhabited by a 
predominantly seminomadic pastoralist population of So-
mali origin who keep cattle, sheep, goats, and camels; and 
carries a wide range of wildlife, including zebras, ante-
lopes, waterbucks, giraffes, warthogs, monkeys, gerenuks, 
dik diks, lions, hyenas, and cheetahs. Livestock interacts 
freely with wildlife, particularly with the large population 
of zebras, waterbucks, and warthogs with which they share 
pastures and watering holes. Local residents keep dogs pri-
marily for security and for herding livestock.
Study Participants
Rickettsial infections were evaluated as potential causes 
of non-malaria fever among 163 patients with fever, muscle 
pain, back pain, headache, and joint pain treated at the Garissa 
Provincial Hospital. A consenting patient was enrolled in the 
study if he or she was >5 years of age (inpatients or outpa-
tients), had an axillary temperature >38°C, had a negative 
test for malaria by blood smear, and had a history of animal 
contact. Animal contact was described as herding, milking, 
or slaughtering. Blood samples were obtained from all con-
senting patients who met the criteria listed. A standardized 
questionnaire was administered by a clinical ofﬁ  cer to record 
the patient’s clinical signs, symptoms, and potential risk fac-
tors, such as contact with animals, consumption of unpas-
teurized dairy products, and unsanitary sources of drinking 
water.
Specimen Collection and Transportation
Approximately 3 mL of blood was collected from each 
patient by venipuncture using sterile technique. Serum 
samples were separated and stored at –20°C before being 
transported to the Kenya Medical Research Institute/US 
Centers for Disease Control and Prevention laboratory in 
Nairobi for acute-phase PCR and serologic testing.
DNA Extraction
DNA was extracted from 300 μL of serum by using 
the QiaAmp DNA Blood Mini Kit (QIAGEN, Valencia, 
CA, USA). The sample DNA was ﬁ  rst treated with 30 μL 
of proteinase K and then lysed with 300 μL of the kit buf-
fer. An equal volume of absolute ethanol was added to the 
lysed sample and the mixture added to the DNA trapping 
columns provided. The columns were then freed of cell de-
bris and other contaminants by a series of washes before 
releasing the matrix-trapped DNA in 50 μL of the kit elu-
tion buffer.
Quantitative Real-time PCRs
Two quantitative real-time PCR (qPCR) assays were 
used to screen for rickettisal nucleic acid in the patients’ 
serum samples: 1) the Rickettsia genus–speciﬁ  c Rick17 
qPCR that ampliﬁ  es and detects a 115-bp segment of the 
17-kDa antigen gene (11) and 2) the tick-borne rickettsiae-
speciﬁ  c qPCR that ampliﬁ  es and detects a 128-bp segment 
of the outer membrane protein (ompB) gene (12). The R. 
felis–speciﬁ  c qPCR that ampliﬁ  es and detects a 129 bp 
segment of the ompB gene was also used, as previously 
described (13,14). The primer and probe oligonucleotides 
were synthesized by Sigma Genosys (The Woodlands, TX, 
USA). Fluorescence was monitored each cycle during the 
annealing step, and data were analyzed with SmartCycler 
software version 2.0d (Cepheid, Sunnyvale, CA, USA).
A plasmid DNA constructed with a PCR product am-
pliﬁ  ed from the R. rickettsii 17-kDa antigen gene was used 
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Figure. North Eastern Province (shaded area), Kenya. The city of 
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as the positive control at 103 copies/reaction for the Rick17 
qPCR . Plasmid DNAs constructed with the target sequenc-
es ampliﬁ  ed from R. rickettsii and R. felis ompB were used 
as positive controls at 103 copies/reaction for tick-borne 
rickettsiae-speciﬁ  c and R. felis qPCRs, respectively. Three 
negative controls included in each run for all qPCRs were 
consistently negative.
PCR, Nested PCR, and Sequencing
Oligonucleotide primers and procedures used for PCR 
and nested PCR ampliﬁ   cation of 17-kDa antigen gene, 
ompB, and R. felis plasmids have been described elsewhere 
(15,16). Brieﬂ  y, the PCR products from the 17-kDa gene, 
ompB, and pRF plasmid were puriﬁ  ed by using a QIAquick 
PCR puriﬁ  cation kit (QIAGEN). No positive controls were 
used in these PCR and nested PCR procedures to decrease 
the chance of contamination; however, a single negative 
control was run with the samples and did not produce any 
products. The BigDye Terminator v 3.0 Ready Reaction 
Cycle Sequencing Kit (Applied Biosystems, Foster City, 
CA, USA) was used in the subsequent sequencing reac-
tions according to manufacturer’s instructions. Sequencing 
products were puriﬁ  ed by using Performa Gel Filtration 
Cartridges (EdgeBioSystems, Gaithersburg, MD, USA), 
and sequencing was performed on an ABI Prism 3100 Ge-
netic Analyzer (Applied Biosystems). The primers used for 
PCR ampliﬁ  cation were the same primers as those used for 
the sequencing reactions. At least 2 sequencing reactions 
were performed for each strand of DNA. Sequences were 
assembled by using Sequencher 4.0 (Gene Codes Corpora-
tion Inc., Ann Arbor, MI, USA), and BLAST searches were 
managed on the National Center for Biotechnology Infor-
mation website (http://blast.ncbi.nlm.nih.gov).
Results
A total of 163 patients whose illnesses met the case 
deﬁ   nition (fever, but not malaria) were seen at Garissa 
Provincial Hospital from August 1, 2006, through June 30, 
2008. No patients had evidence of acute RVF disease either 
by PCR or immunoglobulin (Ig) M testing, but samples ob-
tained from 35 (21.5%) patients were positive for RVF-spe-
ciﬁ  c IgG, indicating previous infection with the RVF virus.
To ascertain whether the patients’ serum samples 
contained molecular evidence of rickettsiae, DNA was ex-
tracted and the preparations were assessed by qPCRfor ge-
nus-speciﬁ  c 17-kDa gene (Rick17 assay) and a segment of 
the ompB, which is speciﬁ  c for tick-borne rickettsiae. Six 
samples of 163 (3.7%) tested were positive by Rick17, but 
none were positive by tick-borne rickettsiae–speciﬁ  c assay, 
suggesting nontick-associated rickettsiae were responsible 
for the patients’ fevers.
To identify which rickettsiae were responsible for the 
patients’ illnesses, a 434-bp fragment from the 17-kDa an-
tigen gene was ampliﬁ  ed from 3 of 6 Rick17-positive sam-
ples by nested PCR. Amplicons (434 bp) were produced 
and represented most of the open reading frame (ORF 480 
bp). They were subsequently sequenced, and a BLAST 
search was conducted. For 3 of 6 Rick17-positive samples, 
amplicons were produced and assessed, and sequences of 
389, 412, and 412 bp were obtained and determined to 
be 100% identical to that provided in GenBank for R. fe-
lis Cal2 (GenBank accession no. CP000054). To conﬁ  rm 
the identity of the rickettsial agents, the 6 DNA sample 
preparations were assessed by an R. felis qPCR selective 
for a unique portion of ompB. All 6 samples were positive 
(Table 1). In addition, after nested PCR for a fragment of 
ompB, two 599-bp amplicons were successfully produced; 
the sequences of these products were 100% identical with 
that of R. felis Cal2 (GenBank accession no. CP000054). 
Of the 6 samples tested, the R. felis plasmid RF was detect-
ed only in sample 1 (GenBank accession no. CP000054), 
and none of the 6 samples produced an RFδ product (Table 
1). Collectively, these results show that R. felis DNA was 
detected in samples from 6 patients even though the rick-
ettsial nucleic acid concentrations were low in the serum 
samples assessed (cycle threshold values 36.4–44.7, data 
not shown).
The 6 patients with positive test results for R. felis were 
7–47 years of age. Three patients were men, 2 herdsmen 
and 1 farmer; 2 of the 3 female patients were housewives 
and 1 was a student 7 years of age. All patients reported 
contact with livestock animals such as cattle, sheep, goats, 
or camels. Although this was not captured in the question-
naire, almost all livestock owners in the region had dogs 
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Table 1. Molecular detection results and characteristics of rickettsial DNA preparations in acute-phase serum samples from 6 patients
who had fever, Garissa Provincial Hospital, North Eastern Province, Kenya, 2006–2008* 
Patient no.  17-kDa gene sequence  ompB sequence  RF plasmid 
1 100% identification with Rickettsia felis  100% identification with R. felis 100% identification with R. felis
2 100% identification with R. felis ––
3– – –
4 – 100% identification with R. felis –
5– – –
6 100% identification with R. felis ––
*ompB, outer membrane protein B gene. All samples were positive by Rick17 PCR and Rfelis qPCR and negative by Trick quantitative PCR (qPCR), RF 
plasmid, and RFG plasmid. Rick17 qPCR is specific for the 17-kDa antigen gene of Rickettsia species; Trick qPCR is specific for a portion of ompB that is 
common to tick-borne rickettsiae; Rfelis qPCR is specific for a portion of ompB that is common to R. felis.RESEARCH
that assisted with livestock herding and security. All of 
the Rickettsia-positive patients reported having had fever 
for 3–8 days, as well as nausea, muscle ache, back pain, 
headache, and joint pain (Table 2). No patients reported 
skin rash, and no information about possible eschars was 
collected. Of the 6 patients, 5 sought care from September 
through February, which is the rainy season, and the other 
was seen in May. None of the Rickettsia-positive patients 
had evidence of jaundice, neurologic signs, bleeding, or vi-
sion impairment. Of 6 R. felis positive patients, 1 (16%) 
had IgG to RVF virus—a prevalence similar to that seen 
in the 163 cases (21.5%). Moreover, all 6 R. felis patients 
had negative tests for leptospirosis and brucellosis (data not 
shown). Though no cases of leptospirosis were identiﬁ  ed 
among the patients, 14.5% of the fever patients had positive 
tests for brucellosis (data not shown).
Discussion
R. felis is the causative agent of ﬂ  ea-borne spotted fe-
ver, an emerging zoonotic disease with wide cosmopolitan 
distribution in >20 countries and 5 continents (17). The 
large dissemination of R. felis and thus the risk for ﬂ  ea-
borne spotted fever can be attributed to the pervasiveness 
of infected arthropods worldwide, including 10 ﬂ  ea species 
(Ctenocephalides felis, C. canis, Xenopsylla cheopis, X. 
brasilliensis, Pulex irritans, Archeopsylla erinacei, Tunga 
penetrans, Ceratophyllus gallinae, Spilospsyllus cuniculi, 
and  Echidnophaga gallinacean) (13,18–21), as well as 
mites and ticks (22,23; J. Jiang and A. Richards, unpub. 
data). The cat ﬂ  ea, C. felis, is considered the primary vector 
for R. felis infections because this arthropod can maintain 
stable infected progeny through transovarial and transtadial 
transmission (24–26), and antibodies against R. felis have 
been detected in animals after they have been exposed to 
infected cat ﬂ  eas (27,28). Hosts for the infected arthropod 
vectors include cats, dogs, opossums, and rodents; how-
ever, no viable R. felis has been isolated from a vertebrate 
host (17), although R. felis DNA has been detected in the 
blood of cats (28), opossums (29), dog (30), rodents (21), 
and humans (14,30,31). However, Hawley et al. (32) did 
not detect R. felis DNA in cats naturally infested with R. 
felis–infected cat ﬂ  eas, nor did the authors of a recent study 
ﬁ  nd an association between rickettsial DNA or antibodies 
and the presence of fever in clinically ill cats (33).
The clinical signs and symptoms of ﬂ  ea-borne spot-
ted fever in humans are similar to those of ﬂ  ea-borne mu-
rine typhus and other rickettsioses and include high fever, 
headache, myalgia, and rash; other manifestations occur, 
such as abdominal pain, nausea, vomiting, cough, es-
char, photophobia, and hearing loss, occur less frequently 
(17,18,31,34,35). All of the 6 patients we described with 
ﬂ  ea-borne spotted fever reported fever, headache, and back 
and joint pain; 4 reported muscle aches; and 3 reported nau-
sea and appetite loss. However, none reported rash.
Because of the nonspeciﬁ  c signs and symptoms of 
ﬂ  ea-borne spotted fever, the disease is difﬁ  cult to diagnose 
clinically. Molecular diagnostics, such as qPCRs, are the 
methods of choice for detecting R. felis and diagnosing 
ﬂ  ea-borne spotted fever because R. felis has yet to be cul-
tured from clinical samples and because serologic assays 
to detect rickettsia-speciﬁ  c antibodies take 1–2 weeks af-
ter onset of disease to reach detectable levels (17,26,35). 
qPCRs have detected rickettsial nucleic acid in various 
clinical specimens (14,15,31). Because of the obligate 
intracellular nature of rickettsiae, clinical samples that in-
clude more infected cells, such as tissue biopsy samples, 
peripheral blood mononuclear cells, and buffy coats, will 
increase the likelihood of obtaining a positive result even 
after patients have received proper treatment with antimi-
crobial drugs (15,36). For this investigation, we used qPCR 
screening assays, PCR and multilocus sequence typing, and 
a species-speciﬁ  c qPCR algorithm to assay acute-phase se-
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Table 2. Clinical and demographic information of patients with flea-borne spotted fever who were treated at Garissa Provincial 
Hospital, North Eastern Province, Kenya, 2006–2008 
Patient
no. Date Age, y/sex  Occupation Clinical signs and symptoms 
Fever 
duration, d 
Animals with which 
patient had contact 
1 2006 Sep 6  47/M Herdsman Back pain, headache, joint pain, appetite 
loss, nausea
8 Cattle, sheep, goats, 
dogs
2 2007 Oct 19 7/F Student Muscle aches, back pain, headache, joint 
pain
7 Unknown* 
3 2007 Oct 30 38/F Housewife Muscle aches, back pain, headache, joint 
pain, chills, malaise, nausea
3 Cattle, sheep, goats, 
dogs
4 2007 Dec 10 20/M Herdsman Cough, back pain, headache, joint pain 3 Cattle, sheep, goats, 
dogs
5 2008 Feb 28  35/M Farmer Cough, muscle aches, back pain, 
headache, joint pain, malaise, fatigue, 
appetite loss, dizziness
7 Unknown*
6 2008 May 2  25/F Housewife Muscle aches, back pain, headache, joint 
pain, chills, malaise, fatigue, appetite 
loss, vomiting, nausea
3 Cattle, sheep, goats, 
dogs
*Responses to the questionnaires indicated these patients came in contact with livestock; however, the responses did not list specific animals. Human Infection with R. felis, Kenya
rum samples to determine the rickettsial agent causing fe-
ver if 6 of 163 patients as R. felis. This algorithm, derived 
initially from the methods of Fournier et al. (37), has been 
used successfully to identify the rickettsial agents in human 
clinical samples (14,15).
We report the detection and clinical signs and symp-
toms of R. felis infection of humans in Kenya. Notably, the 
agents for the rickettsiosis were not R. conorii, R. africae, 
or R. typhi, agents previously known to cause rickettsial dis-
ease in Kenya. Identiﬁ  cation of ﬂ  ea-borne spotted fever and 
its agent R. felis has been reported sporadically in other lo-
cations in Africa, e.g., Democratic Republic of Congo (20), 
Tunisia (38), Algeria (39), Gabon (40), and Egypt (14). 
Therefore, ﬂ  ea-borne spotted fever needs to be included in 
the differential diagnosis of febrile diseases in Kenya.
We identiﬁ  ed illness caused by R. felis in 6 (3.7%) of 
163 fever patients in a 23-month period. This number of 
patients in 1 portion of the country during this short period 
contrasts with a total of only 68 patients known worldwide 
(17). This ﬁ  nding suggests that risk factors associated with 
ﬂ  ea-borne spotted fever in North Eastern Province, Kenya, 
exist and that civilians, military personnel, displaced popu-
lations, and foreign travelers are threatened. Therefore, 
healthcare providers in Kenya and in countries in which 
travelers return from Kenya should be aware of the possi-
bility that febrile patients might be infected with R. felis.
It is also of interest that 1 of 93 patients was found 
in the ﬁ  rst year of the study (August 2006–July 2007), 
whereas 5 of 70 patients were found in the subsequent 11 
months (August 2007–June 2008). Why the number of pa-
tients increased in the two ≈1-year periods is unknown. On-
going surveillance should determine whether this increase 
suggests R. felis infection is an emerging disease or is an 
endemic disease just now being recognized. In addition, 
future studies of rickettsioses in Kenya should include an 
in-depth assessment of the pathogenesis, prevalence, inci-
dence, and risks associated with ﬂ  ea-borne spotted fever.
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